- Home
- LSTA vs BGI Comparison
LSTA vs BGI Comparison
Compare LSTA & BGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LSTA
- BGI
- Stock Information
- Founded
- LSTA 1980
- BGI 1879
- Country
- LSTA United States
- BGI Canada
- Employees
- LSTA N/A
- BGI N/A
- Industry
- LSTA Misc Health and Biotechnology Services
- BGI
- Sector
- LSTA Health Care
- BGI
- Exchange
- LSTA Nasdaq
- BGI Nasdaq
- Market Cap
- LSTA 31.2M
- BGI 26.4M
- IPO Year
- LSTA N/A
- BGI 2005
- Fundamental
- Price
- LSTA $2.52
- BGI $1.07
- Analyst Decision
- LSTA Strong Buy
- BGI
- Analyst Count
- LSTA 1
- BGI 0
- Target Price
- LSTA $15.00
- BGI N/A
- AVG Volume (30 Days)
- LSTA 62.8K
- BGI 350.1K
- Earning Date
- LSTA 02-27-2025
- BGI 11-27-2024
- Dividend Yield
- LSTA N/A
- BGI N/A
- EPS Growth
- LSTA N/A
- BGI N/A
- EPS
- LSTA N/A
- BGI N/A
- Revenue
- LSTA N/A
- BGI $131,596,264.00
- Revenue This Year
- LSTA N/A
- BGI N/A
- Revenue Next Year
- LSTA N/A
- BGI N/A
- P/E Ratio
- LSTA N/A
- BGI N/A
- Revenue Growth
- LSTA N/A
- BGI 4.01
- 52 Week Low
- LSTA $2.19
- BGI $1.03
- 52 Week High
- LSTA $4.20
- BGI $3.98
- Technical
- Relative Strength Index (RSI)
- LSTA 39.52
- BGI 26.81
- Support Level
- LSTA $2.47
- BGI $1.32
- Resistance Level
- LSTA $2.74
- BGI $1.54
- Average True Range (ATR)
- LSTA 0.22
- BGI 0.21
- MACD
- LSTA -0.02
- BGI -0.05
- Stochastic Oscillator
- LSTA 21.82
- BGI 3.99
About LSTA Lisata Therapeutics Inc.
Lisata Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative therapies for the treatment of advanced solid tumors and other major diseases. Its product candidate, LSTA1, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively.
About BGI Birks Group Inc.
Birks Group Inc is a part of the leisure industry. The company designs, develops, produces, and retails fine jewelry, timepieces, and gifts. Its operating segments include Retail and Other. The company generates maximum revenue from the Retail segment. Its retail segment consists of retail operations whereby it operates stores in Canada under the Maison Birks, Brinkhaus, Graff, and Patek Phillippe brands. The other segment consists mainly of wholesale business, e-commerce business, and gold exchange business.